Procera™ and TruAbutment™ announce strategic collaboration to expand access to digital full-arch dentistry

T-Marker™ joins the Procera™ portfolio, delivering a cost-effective entry point into photogrammetry-based workflows for Nobel Biocare, Implant Direct, and Alpha-Bio Tec implant systems

Mahwah, New Jersey, and TruAbutment, Irvine September 24, 2026 – Nobel Biocare and TruAbutment today announced a collaboration to expand access to digital full-arch dentistry through the integration of T-Marker™ technology into the Procera™ portfolio. The collaboration brings together Procera's heritage in precision CAD/CAM prosthetics and digital workflows with TruAbutment's innovative approach to full-arch treatment, creating a more accessible pathway into photogrammetry-based workflows for clinicians and laboratories worldwide.

As demand for full-arch rehabilitation continues to grow, dental professionals are seeking solutions that combine accuracy, efficiency, and affordability. T-Marker™ addresses this need by providing a cost-effective entry point into photogrammetry workflows, enabling more clinicians to adopt advanced digital treatment protocols without the significant investment associated with traditional photogrammetry systems.

Integrated within the Procera™ ecosystem, T-Marker™ will simplify the capture of implant positions, reduce workflow complexity, and lowers barriers to digital adoption. The solution supports full-arch restorative workflows across a broad range of treatment approaches and compatible implant systems, helping clinicians and laboratories improve efficiency while maintaining treatment predictability.

The collaboration reflects a shared commitment to making advanced digital dentistry more accessible. By combining TruAbutment's innovative technology with Procera's extensive expertise in customized CAD/CAM restorations, digital workflows, and clinical education, the collaboration aims to accelerate adoption of digital full-arch protocols and expand treatment opportunities for more patients.

"For decades, Procera™ has been at the forefront of customized CAD/CAM prosthetics, helping dental professionals deliver predictable and patient-centric restorations," said Rosemary O'Neill, VP/GM Procera and Digital Solutions. "By adding T-Marker™ to our Procera™ portfolio, we will be providing clinicians with an affordable, practical entry point into photogrammetry-based workflows. Together with TruAbutment, we are helping simplify digital full-arch treatment and expanding access to technologies that improve clinical efficiency and patient outcomes."

Key benefits of the collaboration

  • A cost-effective entry into photogrammetry-based workflows
  • Simplified digital full-arch treatment workflows for clinicians and laboratories
  • Reduced barriers to adoption of advanced digital protocols
  • Workflow efficiency and treatment predictability

TruAbutment CSO, Sun Kwon commented: "We share a common vision of making digital full-arch dentistry more accessible. Through this collaboration, we are creating a practical and scalable pathway for clinicians to benefit from photogrammetry-based workflows while maintaining efficiency, accuracy, and affordability."

More than a technology integration, this collaboration represents a shared ambition to democratize access to digital full-arch dentistry. By bringing together Procera's legacy of innovation in customized prosthetics and digital workflows with TruAbutment's disruptive approach to full-arch treatment, the partnership creates greater value for clinicians, laboratories, and patients.

T-Marker™ will be introduced in select markets through the Procera™ portfolio, with additional market expansions, educational initiatives, and commercialization plans to follow in the coming months.

About Procera™

For more than three decades, Nobel Biocare’s Procera™ business has been a pioneer in customized CAD/CAM prosthetics and digital dentistry solutions. Through a combination of innovative restorative solutions, digital workflows, and clinical education, Procera™ supports dental professionals in delivering predictable, high-quality outcomes across a broad range of restorative and implant indications.

About TruAbutment™

TruAbutment™ is a leading provider of innovative restorative and digital solutions for implant dentistry. Focused on simplifying clinical workflows and expanding access to advanced technologies, TruAbutment develops precision-engineered products that improve efficiency, predictability, and patient care across digital dentistry workflows.

About Envista Holdings Corporation

Envista is a global leader in the dental industry, uniting more than 30 trusted brands including DEXIS, Kerr, Nobel Biocare, and Ormco under one mission: partnering with dental professionals to improve patients’ lives. With a heritage of category-defining innovation, our brands have shaped modern dentistry: Nobel Biocare was founded by the inventor of titanium implants, Ormco is a pioneer in both traditional and digital orthodontics, DEXIS has long been at the forefront of 2D, 3D and intraoral imaging, and Kerr has supported clinicians for over 135 years. Our high-performing culture is underpinned by our CIRCLe Values and the Envista Business System. Guided by these, we deliver a comprehensive portfolio of technologies, consumables, and services that empower clinicians to provide confident, efficient care today and for the future. Learn more at http://envistaco.com.

Nobel Biocare is a world leader in the field of innovative implant-based dental restorations. The company's portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems (including Nobel Biocare N1™, NobelActive®, NobelParallel™, and the All-on-4® treatment concept), a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems (NobelProcera®), prefabricated prosthetics, and a wide variety of regenerative solutions (creos™). Products are supported by a single digital platform for imaging, diagnostics, and treatment planning (DTX Studio™ suite), and guided and navigated surgery (NobelGuide® and X-Guide®). Nobel Biocare supports its customers through all phases of professional development, offering world-class training and education along with practice support and patient information materials. The company is headquartered in Zurich, Switzerland, and production takes place at sites located in the United States and Sweden. Products and services are available in over 50 countries through subsidiaries and distributors. Nobel Biocare is part the Envista family, one of the largest global dental products companies with more than 30 trusted dental brands. For more information, please visit https://www.nobelbiocare.com.

Related articles